Compare DLXY & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DLXY | VVOS |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 17.7M |
| IPO Year | 2025 | 2020 |
| Metric | DLXY | VVOS |
|---|---|---|
| Price | $0.91 | $1.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 59.3K | ★ 131.2K |
| Earning Date | 03-13-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1077.13 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $273,155,000.00 | $17,317,000.00 |
| Revenue This Year | N/A | $28.86 |
| Revenue Next Year | N/A | $48.70 |
| P/E Ratio | $14.37 | ★ N/A |
| Revenue Growth | N/A | ★ 18.76 |
| 52 Week Low | $0.61 | $1.46 |
| 52 Week High | $7.16 | $7.95 |
| Indicator | DLXY | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 28.96 |
| Support Level | $0.82 | $1.67 |
| Resistance Level | $1.12 | $1.66 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 32.81 | 9.45 |
Delixy Holdings Ltd a holding company that operates through subsidiary. It is engaged in the trading of oil-related products, which can be categorized into crude oil, and oil-based products such as naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. The company has two reportable segments: the Sale of crude oil and the Sale of oil-based products. Key revenue is generated from the Sale of crude oil.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.